TABLE 1.
Characteristics of HIV-infected pregnant women enrolled in the pharmacokinetic study of the TEmAA ANRS 12109 trial, step 1a
| Covariate | Median (min-max) value |
|---|---|
| Maternal body wt at delivery (kg) | 58.3 (46.5-88.1) |
| Gestational age (wk) | 39 (33-42) |
| No. of mothers with vaginal delivery, no. with delivery by cesarean section | 24, 14 |
| Maternal creatinine clearance at enrollment (μmol/liter) | 42.2 (26-88) |
| Neonatal body wt at birth (kg) | 2.7 (2.3-3.6) |
| Neonatal ht at birth (cm) | 48.5 (46.0-53.0) |
| Body surface area at birth (m2) | 0.20 (0.18-0.23) |
a
Data are for 38 pregnant women.